================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported)
July 26, 2004 (July 23, 2004)
GENE LOGIC INC.
(Exact name of registrant as specified in its charter)
- -------------------------- -------------------------- --------------------------
DELAWARE 0-23317 06-1411336
- -------------------------- -------------------------- --------------------------
(State of Incorporation) (Commission (IRS Employer
File Number) Identification Number)
- -------------------------- -------------------------- --------------------------
610 Professional Drive
Gaithersburg, Maryland 20879
(Address of principal executive offices)
(301) 987-1700
(Registrant's telephone number, including area code)
NA
(Former name or former address, if changed since last report)
================================================================================
Item 5. Other Events and Regulation FD Disclosure
On July 23, 2004, Gene Logic Inc. (the "Company") issued a press release
announcing the Company's proposed agreement to acquire a technology program, its
associated research team and other assets from Millennium Pharmaceuticals, Inc.
A copy of the Company's press release is attached hereto as Exhibit 99.1.
Item 7. Financial Statements and Exhibits
(c) Exhibits
Exhibit Number Description
- ----------------------- -------------------------------------------------
99.1 Press Release issued by Gene Logic Inc. dated
July 23, 2004.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Gene Logic Inc.
By: /s/ Philip L. Rohrer, Jr.
-------------------------------
Philip L. Rohrer, Jr.
Chief Financial Officer
Dated: July 26, 2004
EXHIBIT INDEX
Exhibit Number Description
- -------------- -----------
99.1 Press Release issued by Gene Logic Inc. dated July
23, 2004.